Product details
Catalog number PROTQ9NZQ7-3-5ug
Price for PROTQ9NZQ7-3-5ug
Size / count 5 µg
PD-L1 regulates immune responses by binding to the immunoinhibitory receptor PD-1 on activated T-cells and B-cells. This interaction can suppress T-cell responses by inducing apoptosis and arresting cell-cycle progression. In cancer, PD-L1's role in reducing antigen-specific T cells can promote tumor growth and immune evasion. As a result, PD-L1 is considered as a potential therapeutic target for autoimmune diseases and cancer.
The catalog number for Human recombinant PD-L1 protein, AF is PROTQ9NZQ7-3-5ug.
Human recombinant PD-L1 protein, AF is available in the following size(s): 5 µg.
Human recombinant PD-L1 protein, AF is currently made to order / not held in immediate stock. Contact us for lead time.
PD-L1 regulates immune responses by binding to the immunoinhibitory receptor PD-1 on activated T-cells and B-cells. This interaction can suppress T-cell responses by inducing apoptosis and arresting cell-cycle progression. In cancer, PD-L1's role in reducing antigen-specific T cells can promote tumo
Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.
Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.
A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.